HK1070558A1 - Co-beadlet of dha and rosemary and methods of use - Google Patents

Co-beadlet of dha and rosemary and methods of use

Info

Publication number
HK1070558A1
HK1070558A1 HK05100768A HK05100768A HK1070558A1 HK 1070558 A1 HK1070558 A1 HK 1070558A1 HK 05100768 A HK05100768 A HK 05100768A HK 05100768 A HK05100768 A HK 05100768A HK 1070558 A1 HK1070558 A1 HK 1070558A1
Authority
HK
Hong Kong
Prior art keywords
beadlet
rosemary
dha
methods
Prior art date
Application number
HK05100768A
Other languages
English (en)
Inventor
John C. Lang
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28675473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1070558(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of HK1070558A1 publication Critical patent/HK1070558A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
HK05100768A 2002-03-28 2005-01-28 Co-beadlet of dha and rosemary and methods of use HK1070558A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36835202P 2002-03-28 2002-03-28
PCT/US2003/008558 WO2003082249A1 (en) 2002-03-28 2003-03-19 Co-beadlet of dha and rosemary and methods of use

Publications (1)

Publication Number Publication Date
HK1070558A1 true HK1070558A1 (en) 2005-06-24

Family

ID=28675473

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100768A HK1070558A1 (en) 2002-03-28 2005-01-28 Co-beadlet of dha and rosemary and methods of use

Country Status (12)

Country Link
US (2) US20050147698A1 (xx)
EP (1) EP1487418B1 (xx)
JP (2) JP2005527551A (xx)
AR (1) AR039171A1 (xx)
AT (1) ATE398445T1 (xx)
AU (1) AU2003220417B2 (xx)
BR (1) BR0308713A (xx)
CA (1) CA2478154A1 (xx)
DE (1) DE60321669D1 (xx)
DK (1) DK1487418T3 (xx)
HK (1) HK1070558A1 (xx)
WO (1) WO2003082249A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7239755B1 (en) * 1997-07-30 2007-07-03 Lg Electronics Inc. Method of reducing a blocking artifact when coding moving picture
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7815944B2 (en) 2001-06-20 2010-10-19 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US20050147698A1 (en) * 2002-03-28 2005-07-07 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
US7811610B2 (en) 2003-05-22 2010-10-12 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
FR2882894B1 (fr) * 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive
JP2009504657A (ja) 2005-08-09 2009-02-05 メタプロテオミクス,エルエルシー ホップ及びアカシア産物によるプロテインキナーゼ調節
ES2277557B1 (es) * 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
JP2010522190A (ja) 2007-03-19 2010-07-01 メタプロテオミクス, エルエルシー 骨及び関節の健康を助成するための方法と組成物
US8652544B2 (en) * 2008-01-11 2014-02-18 U.S. Nutraceuticals, LLC Chia seed composition
AU2011211461B2 (en) * 2008-01-11 2011-11-17 U.S. Nutraceuticals, Llc D/B/A Valensa International Chia seed composition
US20100159029A1 (en) * 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response
JP5560017B2 (ja) * 2009-10-13 2014-07-23 旭化成ケミカルズ株式会社 脂肪酸、トリグリセリドまたはその混合物を含むマルチコアマイクロカプセルを含有する錠剤およびその製法
CA2774054A1 (en) * 2009-11-06 2011-05-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
CH627449A5 (de) * 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
AU552068B2 (en) * 1981-09-21 1986-05-22 Asama Chemical Co. Ltd. Preservation of edible oils
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
DK88692D0 (da) * 1992-07-06 1992-07-06 Danochemo As Fremgangsmaade til fremstilling af mikrokapsler
JPH0892129A (ja) * 1993-10-08 1996-04-09 Kanagawa Kagaku Kenkyusho:Kk 眼発作治療薬
JPH07236418A (ja) * 1994-02-25 1995-09-12 Kanegafuchi Chem Ind Co Ltd ドコサヘキサエン酸、エイコサペンタエン酸用抗酸化矯臭剤
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
JP3545148B2 (ja) * 1996-01-08 2004-07-21 味の素株式会社 食用マイクロカプセル及びそれを含有する食品
JPH1029938A (ja) * 1996-07-17 1998-02-03 Maruha Corp 虚血性眼疾患の予防および/または治療剤
JP3640005B2 (ja) * 1996-09-25 2005-04-20 日本たばこ産業株式会社 ソフトカプセル用皮膜
JP4028020B2 (ja) * 1997-02-17 2007-12-26 株式会社紀文フードケミファ 動体視力改善剤
JPH10286079A (ja) * 1997-04-16 1998-10-27 Yasumasa Morita 薬草ハーブと不飽和脂肪酸d.h.a(ドコサヘキ サエン酸)を混入した海産物海苔
JP4028642B2 (ja) * 1997-10-07 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 乳化粉末の製造方法
EP0958828A1 (de) * 1998-05-22 1999-11-24 Greither, Peter Präparat auf der Basis der Artischockenpflanze, insbesondere zur Verwendung als Arzneimittel oder Nahrungsergänzungsmittel
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
DE20205184U1 (de) 2002-03-27 2002-12-19 Bartz, Volker, 35440 Linden Blutfettsenker zur oralen Einnahme
US20050147698A1 (en) * 2002-03-28 2005-07-07 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso

Also Published As

Publication number Publication date
DK1487418T3 (da) 2008-09-15
EP1487418A4 (en) 2005-07-13
EP1487418B1 (en) 2008-06-18
JP2006077024A (ja) 2006-03-23
ATE398445T1 (de) 2008-07-15
DE60321669D1 (de) 2008-07-31
WO2003082249A1 (en) 2003-10-09
AU2003220417A1 (en) 2003-10-13
US20050147698A1 (en) 2005-07-07
AR039171A1 (es) 2005-02-09
US20080152710A1 (en) 2008-06-26
JP2005527551A (ja) 2005-09-15
AU2003220417B2 (en) 2009-03-12
CA2478154A1 (en) 2003-10-09
BR0308713A (pt) 2005-01-04
EP1487418A1 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
HK1070558A1 (en) Co-beadlet of dha and rosemary and methods of use
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
AU2003259735A8 (en) Small-mer compositions and methods of use
IL201111A0 (en) Ester compound and medical use thereof
EP1465615A4 (en) TRICYCLIC BISENONE DERIVATIVES AND METHODS OF USE
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
AU2003288902A8 (en) Microcapsules and methods of use
AU2003207698A8 (en) Needle-suture combinations and methods of use
EP1497270A4 (en) AMID COMPOUNDS AND METHOD FOR THEIR USE
EP1551384A4 (en) R-NSAID ESTERS AND ITS USE
AU2003259717A8 (en) Modulators of rabggt and methods of use thereof
EP1499176A4 (en) NEW VIP3 TOXINS AND METHODS OF USE
EP1476150A4 (en) CARBOXY FULLERES AND USE METHOD THEREFOR
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1591062A4 (en) MAGNETOENCEPHALOGRAPHIC DEVICE AND METHOD OF USE
EP1633749A4 (en) DEAZAFLAVIN COMPOUNDS AND METHODS OF USE
GB0615918D0 (en) Composition and its therapeutic use
AU2003215244A8 (en) Complexes and methods of using same
GB0207410D0 (en) Compounds and their therapeutic use
EP1545287A4 (en) VASOREGULATORY COMPOUNDS AND METHODS RELATING TO THEIR USE
EP1622455A4 (en) GEMINI VITAMIN D3 COMPOUNDS AND METHOD FOR THEIR USE
EP1534293A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
AU2003294684A8 (en) Ketoprofen compositions and methods of making them

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120319